Detalhe da pesquisa
1.
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study.
Cancer Immunol Immunother;
73(6): 106, 2024 Apr 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38634928
2.
Implementation of Precision Oncology in Clinical Practice: Results of a National Survey for Health Care Professionals.
Oncologist;
28(6): e324-e330, 2023 06 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36848261
3.
Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study.
Cancer Immunol Immunother;
72(11): 3665-3682, 2023 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37676282
4.
The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancer.
Liver Int;
40(3): 704-711, 2020 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31773848
5.
Cardiovascular safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients: a prospective evaluation.
Future Oncol;
14(5): 443-448, 2018 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29318908
6.
Outcome of Patients with Renal Cell Carcinoma and Multiple Glandular Metastases Treated with Targeted Agents.
Oncology;
92(5): 269-275, 2017.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28208153
7.
Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer.
Future Oncol;
12(4): 493-502, 2016 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26776493
8.
Targeting bone metastatic cancer: Role of the mTOR pathway.
Biochim Biophys Acta;
1845(2): 248-54, 2014 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24508774
9.
Sunitinib, pazopanib or sorafenib for the treatment of patients with late relapsing metastatic renal cell carcinoma.
J Urol;
193(1): 41-7, 2015 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25046616
10.
Prognostic factors in patients receiving third line targeted therapy for metastatic renal cell carcinoma.
J Urol;
193(6): 1905-10, 2015 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25433306
11.
Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors.
Ann Surg Oncol;
22(6): 2094-100, 2015.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25472645
12.
[What patients with cancer think about the dehospitalization. A survey of Cipomo.] / Cosa pensano i pazienti oncologici circa le cure di prossimità. Risultato della survey del Cipomo.
Recenti Prog Med;
115(5): 232-237, 2024 May.
Artigo
em Italiano
| MEDLINE
| ID: mdl-38708534
13.
TEAM Study: Upfront Docetaxel Treatment in Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Real-World, Multicenter, Retrospective Analysis.
Clin Genitourin Cancer;
22(2): 56-67.e16, 2024 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37798164
14.
Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?
Eur Urol Oncol;
7(1): 102-111, 2024 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37481365
15.
Pazopanib in advanced and platinum-resistant urothelial cancer: an open-label, single group, phase 2 trial.
Lancet Oncol;
13(8): 810-6, 2012 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22819172
16.
Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations.
Minerva Urol Nephrol;
75(4): 460-470, 2023 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37530662
17.
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study.
J Natl Cancer Inst;
115(7): 796-804, 2023 07 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37042716
18.
Use of tyrosine kinase inhibitors in patients with metastatic kidney cancer receiving haemodialysis: a retrospective Italian survey.
BJU Int;
110(5): 692-8, 2012 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22364110
19.
Central nervous system metastases from castration-resistant prostate cancer in the docetaxel era.
J Neurooncol;
107(1): 191-6, 2012 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21989810
20.
New emerging targets in advanced urothelial carcinoma: Is it the primetime for personalized medicine?
Crit Rev Oncol Hematol;
174: 103682, 2022 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35421529